These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 794497)

  • 1. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
    Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
    J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo suppression of EL 4 lymphomas by rabbit antitumor sera.
    Ghose T; Guclu A; Faulkner J; Tal J
    J Natl Cancer Inst; 1977 Mar; 58(3):693-700. PubMed ID: 839564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis and immunotherapy of EL4 lymphoma.
    Ghose T; Guclu A; Tai J; Mammen M; Norvell ST
    Eur J Cancer (1965); 1977 Sep; 13(9):925-35. PubMed ID: 913475
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis and cytotoxic effector cells against EL 4 leukemia induced in syngeneic C57BL/6J mice by use of irradiated EL 4 cells.
    Johnson TS; Hudson JL; Feldman ME; Irvin GL
    J Natl Cancer Inst; 1975 Sep; 55(3):561-7. PubMed ID: 51089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.
    Tai J; Guclu A; Ghose T; Norvell S
    Cancer Immunol Immunother; 1983; 15(1):47-53. PubMed ID: 6553507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
    Taniyama T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
    Check JH; Brady LW; Leipold PL; O'Neill EA
    Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.
    Parr I
    Br J Cancer; 1972 Jun; 26(3):174-82. PubMed ID: 5047141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
    Gillette RW; Berringer DC; Wunderlich DA
    J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
    Hawrylko E
    J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
    Rella W; Chaput B
    Oncology; 1978; 35(3):136-42. PubMed ID: 209379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of an AKR lymphoma by antibody and chlorambucil.
    Ghose T; Guclu A; Tai J
    J Natl Cancer Inst; 1975 Dec; 55(6):1353-7. PubMed ID: 1107575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor.
    Reif AE
    J Natl Cancer Inst; 1986 Oct; 77(4):899-908. PubMed ID: 3020300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF; Bodurtha AJ; Mastrangelo MJ; Creech RH
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.